Clinical Trials Directory

Trials / Unknown

UnknownNCT03611166

Proteomics for Chronic Disorder of Consciousness

iTRAQ-Based Proteomics Reveals Potential Biomarkers for Chronic Disorder of Consciousness

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
First Affiliated Hospital of Zhejiang University · Academic / Other
Sex
All
Age
14 Years – 65 Years
Healthy volunteers
Accepted

Summary

Following severe traumatic brain injury, patients may remain unconscious for many years. It is the first proteomic analysis comparing differentially expressed proteins between patients with chronic disorder of consciousness and controls so far. The investigators generated accurate lists of proteomes and identified differences at different disease time courses. The obtained results provide new insight into understanding the molecular mechanisms underlying the chronic disorder of consciousness.

Detailed description

Background: Patients who awake from severely traumatic brain injury (sTBI) may remain unconscious for many years. Although behavioral assessment and functional imaging are currently used as diagnostic tools, the molecular basis underlying chronic condition has yet to be explored. Objective:To explore the molecular basis and identify novel biomarkers for the diagnosis and prognosis of patients with chronic disorder of consciousness. Method: Plasma samples were obtained from patients with chronic disorder of consciousness, and healthy volunteers. A coupled isobaric tag for relative and absolute quantitation (iTRAQ)-based proteomics approach was used to screen differentially expressed proteins (DEPs) between patients and controls. Potential molecular mechanisms were further discussed through bioinformatics analyses. Candidate proteins were validated by enzyme-linked immunosorbent assay (ELISA).

Conditions

Timeline

Start date
2015-11-01
Primary completion
2019-06-15
Completion
2020-01-15
First posted
2018-08-02
Last updated
2018-08-02

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03611166. Inclusion in this directory is not an endorsement.